InvestorBrandNetwork (IBN) Content Platform

Golden Matrix Group (NASDAQ: GMGI), a developer and licensor of online gaming platforms, systems, and gaming content, is announcing the launch of an innovative Artificial Intelligence (“AI”) powered casino game recommender by its subsidiary, Meridianbet. The new AI Casino Recommender feature uses advanced AI to offer personalized game recommendations to players by considering player behavior patterns, previous activities, demographic data, and individual preferences while playing. The AI engine behind the recommender analyzes extensive data to identify patterns and preferences unique to each player. In addition, the AI model is trained daily, ensuring that it stays up-to-date with the latest player behaviors and preferences. The recommender is designed to optimize user engagement and enhance the gaming experience. “This unique state-of-the-art Artificial Intelligence tool is a game changer,” said Meridianbet CEO Zoran Milosevic. “We expect it to generate increased revenues, higher player values as a result of stronger loyalty and retention of players, and most importantly, by providing an enhanced overall experience for Meridianbet players.”

To view the full press release, visit https://ibn.fm/RtjA1

About Golden Matrix Group Inc.

Golden Matrix Group, based in Las Vegas, Nevada, is an established business-to-business (“B2B”) and business-to-consumer (“B2C”) gaming technology company operating across multiple international markets. The B2B division of Golden Matrix develops and licenses proprietary gaming platforms for its extensive list of clients and RKings, its B2C division, operates a high-volume eCommerce site enabling end users to enter paid-for competitions on its proprietary platform in authorized markets. Besides Meridianbet and Expanse Studios, the company also owns and operates MEXPLAY, a regulated online casino in Mexico. The company’s sophisticated software automatically declines any gaming or redemption requests from within the United States, in strict compliance with current U.S. law.

NOTE TO INVESTORS: The latest news and updates relating to GMGI are available in the company’s newsroom at https://ibn.fm/GMGI

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com

InvestorWire is powered by IBN

Knightscope (NASDAQ: KSCP), an innovator in robotics and artificial intelligence (“AI”) technologies focused on public safety, today announced that a California operator of flea markets and swap meets for fun, fashion, food, one-of-a-kind finds, and more has renewed its contract for the 6th consecutive year. The contract renewal will see the client’s K5 Autonomous Security Robot (“ASR”) and 2 K1 Hemispheres continue protecting one of the operator’s many properties in the San Francisco Bay Area.

“The client originally deployed with only one K5 in 2019 to improve safety due to consistent vehicle break-ins and was one of the first to collaborate with its local police department to share information in an effort to positively impact the community. They later added the 2 K1 Hemispheres to expand the scope of capabilities of their overall security programs. Quarterly business reviews revealed that the presence of Knightscope technologies has eliminated night-time vehicle break-ins, and that reported thefts have dropped significantly. As a result, the client is extremely satisfied with Knightscope service because the area is safer for both vendors and visitors to enjoy the market,” the announcement reads.

To view the full press release, visit https://ibn.fm/CNHON

About Knightscope, Inc.

Knightscope builds cutting-edge technologies to improve public safety, and its long-term ambition is to make the United States of America the safest country in the world. For more information or to book a discovery call or demonstration, visit the company’s website at www.knightscope.com.

NOTE TO INVESTORS: The latest news and updates relating to Knightscope are available in the company’s newsroom at https://ibn.fm/KSCP

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com

InvestorWire is powered by IBN

iClick (NASDAQ: ICLK) is a leading enterprise and marketing cloud platform in China that empowers worldwide brands with full-stack consumer lifecycle solutions. The company today announced that its wholly owned subsidiary, Optimix Media Asia Limited, entered into a share purchase agreement on July 19, 2024, to sell its equity interest in Tetris Media Limited to BeihaiOne Limited. According to the announcement, iClick delivers its enterprise solutions in mainland China primarily through Tetris and its subsidiaries. The announcement noted that this strategic move is intended to optimize the company’s operations based on the performance of business units, improve profitability, and realign the business focus to meet market trends and demands in the SaaS sector. Following the sale, iClick will continue to operate its enterprise solutions business in Hong Kong and marketing solutions business in mainland China, Hong Kong and overseas. “The uncertain macroeconomic conditions and the intense competition in the SaaS market in mainland China have resulted in diminished segment margins and operating cashflows. Given the limited growth opportunity, our board of directors has decided to dispose of Tetris and its subsidiaries. We will continue our cost optimization efforts to drive greater operational efficiency, and enhance the company’s capabilities and sustainability. We believe these will help the company ultimately enhance financial performance as well as drive returns to the shareholders,” said Mr. Jian Tang, iClick’s CEO and Co-Founder.

To view the full press release, visit https://ibn.fm/1oznk

About iClick Interactive Asia Group Limited

iClick is a leading enterprise and marketing cloud platform in China. The company’s mission is to empower worldwide brands to unlock the enormous market potential of smart retail. With its leading proprietary technologies, iClick’s full suite of data-driven solutions helps brands drive significant business growth and profitability throughout the full consumer lifecycle. Headquartered in Hong Kong, iClick currently operates in 11 locations across Asia and Europe. For more information, please visit ir.i-Click.com.

NOTE TO INVESTORS: The latest news and updates relating to ICLK are available in the company’s newsroom at http://ibn.fm/ICLK

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com

InvestorWire is powered by IBN

Bravo Multinational (OTC: BRVO), a company dedicated to creating new revenue streams for brands of all types and sizes, is entering the telecommunications sector through its newly established, wholly owned subsidiary, Mobile 13 Inc. According to the announcement, Bravo is working to execute a business plan to become a key player in the telecom industry with the ability to generate revenue by supporting other mobile virtual network operators (“MVNOs”). The announcement noted that an MVNO provides cellular connectivity services by leasing network infrastructure from major mobile network operators (“MNOs”). Through Mobile 13, Bravo plans to become a mobile virtual network enabler (“MVNE”), offering a comprehensive platform for other MVNOs to quickly and efficiently launch their services. Mobile 13 is an MVNO designed to provide mobile phone services to consumers in 50 states and Puerto Rico; the entity specializes in the development of tailored mobile services for small to large employer groups, celebrities and national charities. “We are thrilled to introduce Mobile 13 as our new MVNO venture,” said Bravo Multinational COO Kayla Slick in the press release. “This strategic move aligns with Bravo’s current initiatives of providing turnkey technology and management services, allowing us to potentially expand revenue opportunities and product offerings by creating our own niche brands and partnering with both up-and-coming and well-established brands through white-label licensing agreements. . . . This trend underscores Bravo’s commitment to enhancing the customer experience while leveraging each new subscriber as a potential multiproduct consumer. Bravo’s mission is to bring together cost-effective and high-quality services for consumers, add new revenue streams for our partners and deliver value to our shareholders.”

To view the full press release, visit https://ibn.fm/Txy42

About Bravo Multinational Inc.

Bravo Multinational plans to create new revenue streams for all types and sizes of brands. Bravo Multinational plans to offer a comprehensive suite of turnkey, white-labeled Software as a Service (“SaaS”) solutions, including cellular services, travel club services and Advertising Video on Demand/Subscription Video on Demand (“AVOD/SVOD”) streaming platforms for content distribution. To learn more about the company, visit www.BravoMultinationalInc.com.

NOTE TO INVESTORS: The latest news and updates relating to BRVO are available in the company’s newsroom at https://ibn.fm/BRVO

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com

InvestorWire is powered by IBN

Bravo Multinational (OTC: BRVO), a company dedicated to creating new revenue streams for brands of all types and sizes, is entering the telecommunications sector through its newly established, wholly owned subsidiary, Mobile 13 Inc. According to the announcement, Bravo is working to execute a business plan to become a key player in the telecom industry with the ability to generate revenue by supporting other mobile virtual network operators (“MVNOs”). The announcement noted that an MVNO provides cellular connectivity services by leasing network infrastructure from major mobile network operators (“MNOs”). Through Mobile 13, Bravo plans to become a mobile virtual network enabler (“MVNE”), offering a comprehensive platform for other MVNOs to quickly and efficiently launch their services. Mobile 13 is an MVNO designed to provide mobile phone services to consumers in 50 states and Puerto Rico; the entity specializes in the development of tailored mobile services for small to large employer groups, celebrities and national charities. “We are thrilled to introduce Mobile 13 as our new MVNO venture,” said Bravo Multinational COO Kayla Slick in the press release. “This strategic move aligns with Bravo’s current initiatives of providing turnkey technology and management services, allowing us to potentially expand revenue opportunities and product offerings by creating our own niche brands and partnering with both up-and-coming and well-established brands through white-label licensing agreements. . . . This trend underscores Bravo’s commitment to enhancing the customer experience while leveraging each new subscriber as a potential multiproduct consumer. Bravo’s mission is to bring together cost-effective and high-quality services for consumers, add new revenue streams for our partners and deliver value to our shareholders.”

To view the full press release, visit https://ibn.fm/Txy42

About Bravo Multinational Inc.

Bravo Multinational plans to create new revenue streams for all types and sizes of brands. Bravo Multinational plans to offer a comprehensive suite of turnkey, white-labeled Software as a Service (“SaaS”) solutions, including cellular services, travel club services and Advertising Video on Demand/Subscription Video on Demand (“AVOD/SVOD”) streaming platforms for content distribution. To learn more about the company, visit www.BravoMultinationalInc.com.

NOTE TO INVESTORS: The latest news and updates relating to BRVO are available in the company’s newsroom at https://ibn.fm/BRVO

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com

InvestorWire is powered by IBN

Longeveron (NASDAQ: LGVN), a clinical-stage, regenerative-medicine biotechnology company developing cellular therapies for rare, life-threatening and chronic aging-related conditions, has entered into definitive agreements for the issue and sale of shares of Class A common stock. According to the announcement, the registered direct offering is comprised of up to 2,236,026 shares of LGVN Class A common stock (or common stock equivalents in lieu thereof) issued at a purchase price of $4.025 per share. The company also announced a concurrent private placement that includes issuing and selling of unregistered warrants for to an aggregate of 2,236,026 shares of Class A common stock. The exercise price of the unregistered warrants will be $3.90 per share; the warrants will be immediately exercisable for up to 24 months following the date of issuance. The company anticipates gross proceeds from the offering, which is expected to close on or about July 19, 2024, to reach an estimated $9 million before the deduction of fees and expenses. Longeveron plans to use the funds for ongoing clinical and regulatory development of Lomecel-B(TM) as well as capital expenditures, working capital and other general corporate purposes. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.

To view the full press release, visit https://ibn.fm/Afjqm

About Longeveron Inc. 

Longeveron is a clinical-stage, biotechnology company developing regenerative medicines to address unmet medical needs. The company’s lead investigational product is Lomecel-B(TM), an allogeneic medicinal signaling cell (“MSC”) therapy product isolated from the bone marrow of young, healthy adult donors. Lomecel-B(TM) has multiple potential mechanisms of action encompassing provascular, proregenerative, anti-inflammatory, and tissue repair and healing effects with broad potential applications across a spectrum of disease areas. Longeveron is currently pursuing three pipeline indications: hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease and Aging-Related Frailty. Lomecel-B Development programs have received five separate and distinct FDA designations: for the HLHS program – Orphan Drug designation, Fast Track designation, and Rare Pediatric Disease designation; and, the Alzheimer’s Disease program – Regenerative Medicine Advanced Therapy (“RMAT”) designation and Fast Track designation. To learn more about the company, visit www.Longeveron.com.

NOTE TO INVESTORS: The latest news and updates relating to LGVN are available in the company’s newsroom at https://ibn.fm/LGVN

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com

InvestorWire is powered by IBN

IGC Pharma (NYSE American: IGC) today announced that Alliance Global Partners (“AGP”) has issued an analyst coverage research report on the company’s common stock. AGP issued a “Buy” recommendation and a $3.50 price target. “All reports on IGC Pharma prepared by analysts represent the views of those analysts and are not necessarily those of IGC Pharma. IGC is not responsible for the content, accuracy, or timelines provided by analysts. By referring to these analysts or distributing their opinions, IGC does not in any way commit itself to the validity of such information, conclusions, or recommendations,” the announcement read.

To view the full analyst report, visit https://ibn.fm/Rujlt

To view the full press release, visit https://ibn.fm/Jr5l3

About IGC Pharma Inc.

IGC is focused on Alzheimer’s disease, developing innovative therapies to address this devastating illness. The company’s mission is to transform the landscape of Alzheimer’s treatment with a robust pipeline of five promising drug candidates. IGC-AD1, with previously disclosed interim results, is in a Phase 2 clinical trial for agitation in dementia associated with Alzheimer’s (clinicaltrials.gov, NCT05543681). The remaining four molecules are in the pre-clinical stage of development. TGR-63 has been shown to disrupt the progression of Alzheimer’s by targeting Aβ plaques, a key hallmark of Alzheimer’s. IGC-1C targets tau protein and neurofibrillary tangles, representing a forward-thinking approach to Alzheimer’s therapy. IGC-M3 aims to inhibit the aggregation of Aβ plaques, potentially impacting early-stage Alzheimer’s. LMP is designed to target multiple hallmarks of Alzheimer’s including plaques and tangles for a comprehensive approach to the disease. In addition to its drug development pipeline, IGC is attempting to harness the power of artificial intelligence to develop early disease detection models, optimize clinical trials, and explore new applications for its drugs.

NOTE TO INVESTORS: The latest news and updates relating to IGC are available in the company’s newsroom at https://ibn.fm/IGC

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com

InvestorWire is powered by IBN

Canada Nickel (TSX.V: CNC) (OTCQX: CNIKF), a company that is advancing the next generation of nickel-sulphide projects, announced an initial mineral resource estimate (“MRE”) for its 100% owned Deloro Nickel Sulphide Project, which is located near Timmins, Ontario, in the heart of the prolific Timmins-Cochrane mining camp. According to the MRE, seven exploration rigs are currently drilling across the Timmins Nickel District, and the company anticipates the first of seven new nickel resources to be published by end of the first quarter of 2025, which will demonstrate the potential scale of the Timmins Nickel District. In addition, the project has initial Indicated Resource of 81 million tonnes grading 0.25% nickel containing 202kt of nickel plus a further Inferred Resource of 357 million tonnes grading 0.25% nickel containing 885kt of nickel. “We are very pleased with the size of this initial resource on Deloro, particularly given the relatively small scale of the target footprint relative to the 20+ targets in our portfolio,” said Canada Nickel CEO Mark Selby in the press release. “Deloro has an advantageous location near both Timmins and the mining and processing infrastructure at the Dome Mill, and benefits from a relatively low overburden of an average of just 9 meters. Our exploration program continues to successfully demonstrate the potential of the Timmins Nickel District and now has seven drill rigs operating – four drilling on our Mann Central and Mann Northwest properties, two completing the next phase of drilling at our Reid project, and one targeting the east end of our Reaume project. Updates on drilling at each of these properties will be provided as assay results are compiled.”

To view the full release, visit https://ibn.fm/gNwnA

About Canada Nickel Company Inc.

Canada Nickel is advancing the next generation of nickel-sulphide projects to deliver nickel required to feed the high-growth electric vehicle and stainless-steel markets. Canada Nickel has applied in multiple jurisdictions to trademark the terms NetZero Nickel(TM), NetZero Cobalt(TM) and NetZero Iron(TM), and is pursuing the development of processes to allow the production of net-zero carbon nickel, cobalt and iron products. Canada Nickel provides investors with leverage to nickel in low political-risk jurisdictions. Canada Nickel is currently anchored by its 100% owned flagship Crawford Nickel-Cobalt Sulphide Project in the heart of the prolific Timmins-Cochrane mining camp. For more information about the company, visit www.CanadaNickel.com.

NOTE TO INVESTORS: The latest news and updates relating to CNIKF are available in the company’s newsroom at https://ibn.fm/CNIKF

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com

InvestorWire is powered by IBN

Knightscope (NASDAQ: KSCP), an innovator in robotics and artificial intelligence (“AI”) technologies focused on public safety, has received a new contract from a Nevada-based college. According to the announcement, the college has purchased eight of Knightscope’s K1 Blue Light Towers.

According to the announcement, integrated solar panels will power the devices, creating a completely wireless operation that includes mass notification speakers and faceplate cameras. The contract also includes a full-service maintenance plan and the Knightscope Emergency Management System (“KEMS”) software.

“College campus safety is a top priority that ensures a secure and enjoyable environment for students, faculty and visitors,” said the company in the press release. “Emergency communications play a vital role in that mission by providing an extra layer of protection with reliable, one-touch access to services such as police, fire and EMS. Those on campus are encouraged to use the new Blue Light Tower without hesitation in times of danger, personal crisis, medical emergencies, to report suspicious behavior or activities, or for accidents.”

In addition, Knightscope noted that its Robot Roadshow is slated to be at the 18th annual Veterans Affairs Healthcare Summit, held in Arlington, Virginia, on July 23–24, 2024. The roadshow will be located outside the entrance of the Crystal Gateway Marriott during event exhibit hours.

“The Robot Roadshow is an engaging experiential event, allowing potential clients and the general public to participate in expert-led demonstrations in a climate controlled, space-age ‘pod’ where attendees may experience the self-driving, electric technologies that are already helping protect the places people live, work, study and visit,” the announcement stated. “Visitors will be able to interact directly with Autonomous Security Robots, test a blue light emergency phone and see the Knightscope Security Operations Center user interface in action.”

To view the full press release, visit https://ibn.fm/rkLFv

About Knightscope, Inc.

Knightscope builds cutting-edge technologies to improve public safety. The company’s long-term ambition is to make the United States of America the safest country in the world. For more information about the company, please visit www.Knightscope.com.

NOTE TO INVESTORS: The latest news and updates relating to KSCP are available in the company’s newsroom at https://ibn.fm/KSCP

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com

InvestorWire is powered by IBN

Longeveron (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for rare, life-threatening and chronic aging-related conditions, today announced that the U.S. Food and Drug Administration (“FDA”) has granted Fast Track designation to Lomecel-B(TM) for the treatment of mild Alzheimer’s Disease. Lomecel-B(TM) is a proprietary, scalable, allogeneic, investigational cellular therapy being evaluated across multiple indications. The Fast Track designation process aims to facilitate the development and expedite the review of new therapies intended to treat serious or life-threatening conditions and that demonstrate the potential to address unmet medical needs. According to the announcement, the Fast Track designation granted to the Lomecel-B(TM) Alzheimer’s Disease program is the fifth special regulatory designation received for Lomecel-B(TM). “Fast Track designation is another important milestone for Longeveron and Lomecel-B(TM), which, along with the recent granting of Regenerative Medicine Advanced Therapy (“RMAT”) designation, recognizes the critical need for quickly advance novel, safe and effective investigational treatments for Alzheimer’s Disease, which has a devastating impact on patients and their families,” said, Wa’el Hashad, CEO of Longeveron.

To view the full press release, visit https://ibn.fm/iLqbj

About Longeveron Inc.

Longeveron is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. The company’s lead investigational product is Lomecel-B(TM), an allogeneic medicinal signaling cell (“MSC”) therapy product isolated from the bone marrow of young, healthy adult donors. Lomecel-B has multiple potential mechanisms of action encompassing pro-vascular, pro-regenerative, anti-inflammatory, and tissue repair and healing effects with broad potential applications across a spectrum of disease areas. Longeveron is currently pursuing three pipeline indications: hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease, and Aging-related Frailty. The Lomecel-B HLHS program has received three distinct and important U.S. FDA designations: Orphan Drug, Fast Track and Rare Pediatric Disease designations. For more information about the company, visit www.Longeveron.com.

NOTE TO INVESTORS: The latest news and updates relating to LGVN are available in the company’s newsroom at http://ibn.fm/LGVN

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com

InvestorWire is powered by IBN

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs with improved efficacy and safety, has named a new chief financial officer. According to the announcement, Russell L. Skibsted has accepted the new assignment, effective immediately; Skibsted succeeds James Stanker, who is retiring but will serve in an advisory role to assist in the transition. Skibsted has spent almost three decades working in the pharmaceutical industry, gaining an invaluable expertise in financial management, global business development, capital markets, investor relations and operations. He has served in both public and private life sciences companies at all stages of development. His positions have included senior vice president and CFO at Alimera Sciences; executive vice president, CFO and chief business officer at Rockwell Medical; and CFO at BioTime, among others. “We are delighted to welcome Russell to Processa’s executive team,” said Processa Pharmaceuticals CEO George Ng in the press release. “His proven record in finance and capital markets combined with a deep understanding of the complexities inherent in the life sciences make him an ideal fit for Processa. With three decades of highly relevant experience, Russell is a seasoned executive and will be a tremendous asset to the company as we advance our pipeline through the clinic.”

To view the full press release, visit https://ibn.fm/zZUmc

About Processa Pharmaceuticals Inc.

Processa is a clinical-stage pharmaceutical company focused on developing the next-generation chemotherapy (“NGC”) drugs to improve the safety and efficacy of cancer treatment. By combining its novel oncology pipeline with proven cancer-killing active molecules and the Processa Regulatory Science Approach as well as experience in defining Optimal Dosage Regimens for FDA approvals, the company will not only provide better therapy options to cancer patients but will also increase the probability of FDA approval for its next-generation chemotherapy drugs following an efficient path to approval. Processa’s NGC drugs are modifications of existing FDA-approved oncology drugs resulting in an alteration of the metabolism and/or distribution of these drugs while maintaining the existing mechanisms of killing the cancer cells. The company’s approach to drug development is based on more than 30 years of expertise to efficiently design and conduct clinical trials that demonstrate a positive benefit/risk relationship. The Processa team has a track record of obtaining more than 30 indication approvals across almost every division of the FDA. Using its proven Regulatory Science Approach, the Processa team has experience defining the Optimal Dosage Regimen using the principles of the FDA’s Project Optimus Oncology initiative. The advantages of Processa’s NGCs are expected to include fewer patients experiencing side effects that lead to dose discontinuation, more significant cancer response and a greater number of patients — in excess of 200,000 for each NGC drug — who will benefit from each NGC drug. Processa is currently 1) starting to initiate sites for the phase 2 study that will identify the optimal dosage regimen for Next Generation Capecitabine (PCS6422 and capecitabine to treat breast, metastatic colorectal, gastrointestinal, pancreatic and other cancers); 2) defining the design of the Next Generation Gemcitabine (PCS3117 to treat pancreatic, biliary, lung, ovarian, breast and other cancers) phase 2 optimal dosage regimen study to discuss with the FDA; and 3) defining the formulation and toxicology program for Next Generation Irinotecan (PCS11T to treat lung, colorectal, gastrointestinal, pancreatic and other cancers). For more information, visit the company’s website at www.ProcessaPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to PCSA are available in the company’s newsroom at https://ibn.fm/PCSA

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com

InvestorWire is powered by IBN

Uranium Energy (NYSE American: UEC), a U.S.-based uranium mining and exploration company, has announced the results of its annual general meeting of stockholders, which was held July 16, 2024. During the meeting, several proposals were voted on and ratified, including the election of six individuals to the company’s board of directors. Those individuals included Amir Adnani, Spencer Abraham, Vincent Della Volpe, David Kong, Gloria Ballesta and Trecia Canty. In addition, PricewaterhouseCoopers LLP was appointed as the company’s independent registered accounting firm, the company’s 2024 Stock Incentive Plan was approved, and the company’s executive compensation was approved. After the meeting was concluded, the board of directors reappointed the executive officers of the company. Those appointments included Amir Adnani as president and CEO; Pat Obara as secretary, treasurer and chief financial officer; Scott Melbye as executive vice president; and Brent Berg as senior vice president, U.S. Operations.

To view the full press release, visit https://ibn.fm/60Xdz

About Uranium Energy Corp.

Uranium Energy Corp is the fastest-growing supplier of the fuel for green-energy transition to a low-carbon future. UEC is the largest, diversified North American-focused uranium company, advancing the next generation of low-cost, environmentally friendly, in-situ recovery (“ISR”) uranium projects in the United States and high-grade conventional projects in Canada. The company has two production-ready, ISR hub-and-spoke platforms in south Texas and Wyoming. These two production platforms are anchored by fully operational central processing plants and served by seven U.S. ISR uranium projects with all their major permits in place. Additionally, UEC has diversified uranium holdings including: (1) one of the largest physical uranium portfolios of North American-warehoused U3O8; (2) a major equity stake in Uranium Royalty Corp., the only royalty company in the sector; and (3) a Western Hemisphere pipeline of resource-stage uranium projects. The company’s operations are managed by professionals with decades of hands-on experience in the key facets of uranium exploration, development and mining. For more information about the company, visit www.UraniumEnergy.com.

NOTE TO INVESTORS: The latest news and updates relating to UEC are available in the company’s newsroom at https://ibn.fm/UEC 

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com

InvestorWire is powered by IBN

The United States government’s recent memorandum with major social media companies, including Meta Platforms (NASDAQ: META), X and Snap (NYSE: SNAP), marks a significant step in the fight against the distribution of synthetic drugs online. Snap, known for its Snapchat application, is at the forefront of this initiative, showcasing its commitment to corporate responsibility. This collaboration aims to leverage the extensive reach and influence of these platforms to address a critical public health concern.

Snap, alongside its peers Meta and X, plays a pivotal role in the digital ecosystem, with millions of users engaging on their platforms daily. The agreement to curb the distribution of synthetic drugs not only highlights their social responsibility but also sets a precedent for how tech companies can work alongside government bodies to tackle complex issues. For Snap, this move is particularly noteworthy as it could enhance its reputation among users and regulators, emphasizing its dedication to creating a safe online environment.

The memorandum’s focus on preventing the distribution of synthetic drugs through social media platforms is a testament to the evolving role of these companies in society. By taking a stand against such activities, Snap and its counterparts are acknowledging the impact they have on public health and safety. Although the specific commitments and strategies were not disclosed, the initiative itself is a clear indication of their willingness to be part of the solution.

For Snap, the implications of this agreement extend beyond the immediate goal of curbing drug distribution. It could potentially influence user trust, as users may feel more secure knowing that the platform is actively working to eliminate harmful content. Additionally, this proactive approach could foster a more positive relationship with regulatory bodies, which is crucial for navigating the complex legal landscape of social media.

In summary, the memorandum signed between the U.S. government and major social media companies, including Snap, represents a collaborative effort to address a significant public health issue. For Snap, this initiative not only underscores its commitment to corporate responsibility but also has the potential to positively impact its relationship with users and regulators. By participating in this agreement, Snap is demonstrating its role as a responsible actor in the digital age, committed to ensuring the safety and well-being of its community.

To view the company’s most recent earnings release, visit https://ibn.fm/Fc4Iq

About Snap Inc.

Snap Inc. is a technology company. We believe the camera presents the greatest opportunity to improve the way people live and communicate. We contribute to human progress by empowering people to express themselves, live in the moment, learn about the world, and have fun together. For more information, visit the company’s website at www.Snap.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com

InvestorWire is powered by IBN

Knightscope (NASDAQ: KSCP), an innovator in robotics and artificial intelligence (“AI”) technologies focused on public safety, is announcing a new product. According to the announcement, the company now offers the Knightscope K1 Laser solution for physical security; the device utilizes lidar-based technology to detect people and objects along with integrated perception software for enhanced situational awareness.

The new K1 Laser, which operates under adverse weather and low or no-light conditions, can be installed on fixed structures; it can also be used in combination with Knightscope’s K1 portfolio of stationary technologies, which are deployed in an array of locations, including parking lots and structures, building interiors, university campuses, transit stations and more. Knightscope K1 Laser clients may choose to layer the lidar perception software for security applications featuring advanced detection and alerts backed by the company’s Risk & Threat Exposure team.

“Our Knightscope K1 Laser is designed to drive exceptional value from lidar systems, providing high accuracy in detecting, classifying, and tracking people, vehicles and objects,” said Knightscope chair and CEO William Santana Li in the press release. “Our products will also integrate with lidar-based perception software, which can reduce false alarms and missed events by as much as 95%, ensuring that we provide our clients with the highest levels of safety in covered areas with reliable monitoring and detections, especially for perimeter security.”

To view the full press release, visit https://ibn.fm/5asjw

About Knightscope, Inc.

Knightscope builds cutting-edge technologies to improve public safety. The company’s long-term ambition is to make the United States of America the safest country in the world. For more information about the company, please visit www.Knightscope.com.

NOTE TO INVESTORS: The latest news and updates relating to KSCP are available in the company’s newsroom at https://ibn.fm/KSCP

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com

InvestorWire is powered by IBN

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, today announced a new contract with a national employer to provide its cardiometabolic solution with integrated support for GLP-1s to employees beginning in the third quarter of 2024. “The challenges associated with GLP-1s make a behavior change support program critical for any payer or employer in order to deliver alongside access to the medications. Dario’s expertise in utilizing its platform to support behavior change and proven outcomes gives employers confidence in our ability to drive lasting results, especially now as we integrated Twill engagement capabilities and behavioral support with access to providers and peer-to-peer communities as integrated components in Dario’s intelligent platform,” said Steven Nelson, chief commercial officer at Dario. “We believe that employers, payers and pharmaceutical companies see tremendous value in the combination of Dario and Twill as an integrated offering to help solve the urgent challenges of GLP-1 management. In fact, we expect at least ten of our employer clients to adopt our integrated offering in the next quarter or so to leverage the power of our enhanced multi-chronic condition platform.”

To view the full press release, visit https://ibn.fm/gO2NT

About DarioHealth Corp.

DarioHealth is a leading digital health company revolutionizing how people with chronic conditions manage their health through a user-centric, multi-chronic condition digital therapeutics platform. Its platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health. Dario’s user-centric platform offers people continuous and customized care for their health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention and results, making the right thing to do the easy thing to do. Dario provides its highly user-rated solutions globally to health plans and other payers, self-insured employers, providers of care and consumers. To learn more about Dario and its digital health solutions, or for more information, visit www.DarioHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com

InvestorWire is powered by IBN

Amesite (NASDAQ: AMST), a leading artificial intelligence (“AI”) software company offering a cloud-based learning platform for business and education markets, has unveiled an innovative and proprietary app designed for personal safety and security. The company has opened beta registration for the app, called PREACTO(TM). According to the announcement, the new web app utilizes artificial intelligence (“AI”) to provide key tools for people who prioritize safety and security; the app can help users proactively assess threats, plan safe routes and activities, update law enforcement, notify family and friends, and more. The company noted that the app also includes active shooter preparedness content developed in collaboration with Chris Grollnek, founder of the Active Shooter Prevention Project. PREACTO features are designed to make activities such as attending public events, taking walks, exercising and visiting local parks more safe and secure. These features include RescueCall, CrimeMap, SafeZone, SafePath, WeaponSight and IncidentReporter. “Following the successful launch of NurseMagic(TM) that uniquely offers AI tools directly to nurses to make their work more efficient and reduce their stress, we are now able to offer PREACTO by leveraging our infrastructure and the learning and guidance of global expert Chris Grollnek,” said Amesite CEO Dr. Ann Marie Sastry in the press release. “Together, we aim to keep organizations and communities safer, 24/7 and globally, providing our users with powerful, easy-to-use tools to take charge of their own personal security.”

To view the full press release, visit https://ibn.fm/v9MPk

About Amesite Inc.

Amesite, an education-tech SaaS company, offers its proprietary learning platform and content services to deploy affordable and effective artificial intelligence (“AI”) for white-labeled online learning programs for colleges and universities. The company’s technology platform leverages cutting-edge AI to offer an innovative out-of-the box, AI-powered learning ecosystem, complete with 24/7 learner support, up-to-date content and ready-to-go programs to quickly deploy and generate revenue. With the announcement of NurseMagic(TM), Amesite has entered the business-to-consumer (“B2C”) AI app market. Amesite has also announced its intention to deliver other apps on its infrastructure including a public safety app that offers training and preparedness for active-shooter response. For more information about the company, please visit www.Amesite.io.

NOTE TO INVESTORS: The latest news and updates relating to AMST are available in the company’s newsroom at https://ibn.fm/AMST

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com

InvestorWire is powered by IBN

Silo Pharma (NASDAQ: SILO), a developmental-stage biopharmaceutical company focused on developing novel formulations and drug-delivery systems for traditional therapeutics and psychedelic treatments, has entered into an exclusive global license agreement. The agreement outlines the company’s intentions to further develop, manufacture and commercialize SPC-14, SILO’s Alzheimer’s drug. According to the announcement, the company plans to follow the U.S. Food and Drug Administration’s 505(b)(2) pathway to approval, which will result in shorter clinical timelines and reduced drug-development costs. A novel therapeutic that targets glutamate receptor NDMAR and serotonin type 4 receptor 5HT4, SPC-14 is designed to treat cognitive and neuropsychiatric symptoms in Alzheimer’s disease. The company noted that in its most recent small-animal preclinical study, the drug showed effectiveness against luteinizing hormone (“LH”) stress in decreasing learned helplessness, perseverative behavior and hyponeophagia, a measure of anxiety. “In our view, our exclusive license for SPC-14 gives us the potential to meet a large unmet medical need,” said Silo Pharma CEO Eric Weisblum in the press release. “If approved, we believe SPC-14 could bring hope and relief for many families and patients. Early preclinical studies have shown stress reduction and cognitive improvement.”

To view the full press release, visit https://ibn.fm/bcATz

About Silo Pharma Inc.

Silo Pharma is a developmental-stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions and central nervous system (“CNS”) diseases. Silo focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug-delivery systems. The company’s lead program, SPC-15, is an intranasal treatment targeting post-traumatic stress disorder (“PTSD”) and stress-induced anxiety disorders. SP-26 is a time-release, ketamine-loaded implant for fibromyalgia and chronic pain relief. Silo’s two preclinical programs are SPC-14, an intranasal compound for the treatment of Alzheimer’s disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (“MS”). Silo’s research and development programs are conducted through collaborations with universities and independent laboratories. For more information about the company, visit www.SiloPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to SILO are available in the company’s newsroom at https://ibn.fm/SILO

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com

InvestorWire is powered by IBN

Battery Mineral Resources (TSX.V: BMR) (OTCQB: BTRMF) (“BMR”) has announced the first shipments of copper concentrates related to the offtake agreement with Anglo American Sur. S.A. (“Anglo” or “Anglo American”) a division of Anglo-American PLC. According to the announcement, the company has supplied 503.74 dry metric tonnes (“DMT”) of copper concentrates to Anglo’s Chagres smelter in Catemu, Chile. The company will continue to increase results with a goal of producing approximately 1,400 DMT per month in the near term and reaching up to 2,800 DMT of copper concentrate production per month by year-end. “This initial copper concentrate shipment marks a significant stride towards positive cash flow, in line with Battery’s goal of building a mid-tier copper producer,” said the company’s CEO Martin Kostuik. “As we generate cash flow from copper sales, including leveraging thirty-party sources of mill feed such as those from Anglo, we will also continue to ramp up mine-sourced mill feed from our Cinabrio, San Andres and Dalmacia mines to achieve full production.”

To view the full press release, visit https://ibn.fm/neSoR

About Battery Mineral Resources Corp.

Battery Mineral Resources’ mission is to build a mid-tier copper producer and it has recently initiated mine and mill operations at the Punitaqui Mining Complex, a historic copper-gold-silver producer, in the Coquimbo region of Chile. Battery Mineral Resources is unique because it leverages the inherent value from its 100% owned subsidiary, ESI Energy Services Inc., a renewable energy equipment rental and sales company. The company’s portfolio also consists of two cobalt assets and one graphite asset located in North America, South America and South Korea. The company is focused on providing shareholders accretive exposure to copper and the global mega-trend of electrification while being focused on growth through cash-flow, exploration, and acquisitions in favorable mining jurisdictions. For more information about the company, visit www.BMRCorp.com.

NOTE TO INVESTORS: The latest news and updates relating to BTRMF are available in the company’s newsroom at https://ibn.fm/BTRMF

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com

InvestorWire is powered by IBN

Siyata Mobile (NASDAQ: SYTA, SYTAW), a global developer and vendor of Push-to-Talk (“PTT”) over Cellular (“PoC”) handsets and accessories, has received an order for its SD7 PTT handsets and VK7 Vehicle Kits as well as other related accessories. The order came from Bensalem Township School District, a suburban school district located in Bucks County, Pennsylvania, which serves more than 7,000 students. The school district’s bus transportation services will be using the handsets and kits. An official for the school district stated that the district selected Siyata’s handsets and vehicle kits primarily for their ease of use as well as the flexibility offered by a second channel; the new equipment will be replacing previous devices that were cumbersome and complicated to operate. “We are honored to equip yet another school district’s schools and bus operations with our SD7 handsets and VK7 vehicle kits,” said Siyata Mobile CEO Marc Seelenfreund in the press release. “We are confident the operators will find the devices easy to use and enable them to focus on the safe and timely shuttling of students to and from schools across the district.”

To view the full press release, visit https://ibn.fm/fhsDl

About Siyata Mobile Inc.

Siyata Mobile is a business-to-business (“B2B”) global developer and vendor of next-generation, Push-to-Talk (“PTT”) over Cellular (“POC”) handsets and accessories. Its portfolio of rugged PTT handsets and accessories enables first responders and enterprise workers to instantly communicate, over a nationwide cellular network of choice, to increase situational awareness and save lives. Police, fire and ambulance organizations as well as schools, utilities, security companies, hospitals, waste-management companies, resorts and many other organizations use Siyata PTT handsets and accessories. In support of its Push-to-Talk handsets and accessories, Siyata also offers enterprise-grade, in-vehicle solutions and cellular booster systems enabling customers to communicate effectively when they are in their vehicles, even in areas where the cellular signal is weak. Siyata sells its portfolio through leading North American cellular carriers, and through international cellular carriers and distributors. For more information about the company, visit www.SiyataMobile.com or www.UnidenCellular.com.

NOTE TO INVESTORS: The latest news and updates relating to SYTA are available in the company’s newsroom at http://ibn.fm/SYTA

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com

InvestorWire is powered by IBN

Volcon (NASDAQ: VLCN), an all-electric power sports company producing high-quality and sustainable electric vehicles for the outdoor community, recently closed a registered direct offering. The company secured aggregate gross proceeds of approximately $12 million in the transaction that closed on July 12, 2024. Aegis Capital Corp. acted as the exclusive placement agent for the offering.

To view the full press release, visit https://ibn.fm/xoB2G

About Volcon Inc.

Based in the Austin, Texas area, Volcon was founded as the first all-electric power sports company producing high-quality and sustainable electric vehicles for the outdoor community. Volcon electric vehicles are the future of off-roading, not only because of their environmental benefits but also because of their near-silent operation, which allows for a more immersive outdoor experience. Volcon’s vehicle roadmap includes both motorcycles and UTVs. For more information about the company, visit www.Volcon.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com

InvestorWire is powered by IBN